Please do not adjust margins
ChemComm
Page 4 of 5
COMMUNICATION
Journal Name
4
5
Ed. 2011, 50, 1101; c) X.-H. He, Y.-L. JDi,OCI.: 1P0e.1n0g3,9/BD.0HCaCn0,28A7d6vB.
Synth. Catal. 2019, 361, 1923.
a) J. Meinwald, T. H. Jones, J. Am. Chem. Soc. 1978, 100, 1883;
b) B. Roach, T. Eisner, J. Meinwald, J. Org. Chem. 1990, 55,
4047; c) M. Ono, K. Nishimura, H. Tsubouchi, Y. Nagaoka, K.
Tomioka, J. Org. Chem. 2001, 66, 8199; d) G. Zhao, A. J. Souers,
M. Voorbach, H. D. Falls, B. Droz, S. Brodjian, J. Med. Chem.
2008, 51, 380.
catalyzed asymmetric [3 +2] cycloaddition of terminal allenoate
with trifluoromethyl enone is shown in Scheme 5. Nucleophilic
attack of chiral phosphine catalyst (S)-P4 on allenoate 2a
generates zwitterionic intermediate I which stabilized by
hydrogen-bonding interactions of N–H and carbonyl group.
Intermediate II was then created from the less hindered -
addition. The subsequent intramolecular Michael addition,
followed by proton transfer and release of catalyst, afford the
final [3+2] cycloaddition product 3aa.
6
7
a) C. Zhang, X. Lu, J. Org. Chem. 1995, 60, 2906; b) Y. Du, X. Lu,
Y. Yu, J. Org. Chem. 2002, 67, 8901; c) Y. Du, X. Lu, J. Org.
Chem. 2003, 68, 6463.
O
O
Ph
CF3
P4
(S)-
(2.5 mol%)
EtO2C
+
CF3
Ph
toluene, - 20 oC, 1.5 h
For selected reviews related to the cycloaddition of allenes
with olefins, see: a) X. Lu, C. Zhang, Z. Xu, Acc. Chem. Res.
2001, 34, 535; b) L.-W. Ye, J. Zhou, Y. Tang, Chem. Soc. Rev.
2008, 37, 1140; c) B. J. Cowen, S. J. Miller, Chem. Soc. Rev.
2009, 38, 3102; d) Q.-Y. Zhao, Z. Lian, Y. Wei, M. Shi, Chem.
Commun. 2012, 48, 1724; d) Y. C. Fan, O. Kwon, Chem.
Commun. 2013, 49, 11588; e) Z. Wang, X. Xu, O. Kwon, Chem.
Soc. Rev. 2014, 43, 2927; f) L. Yang, J. Ma, Acta Chim. Sinica,
2016, 74, 130.
W. Zhou, H. Wang, M. Tao, C.-Z. Zhu, T.-Y. Lin, J. Zhang, Chem.
Sci. 2017, 8, 4660.
a) W. Chen, E. F. Igboko, X. Lin, H. Lu, F. Ren, P. B. Wren, Z. Xu,
T. Yang, L. Zhu, WO2015181186, 2015; b) C. Dolente, B.
Fasching, V. Runtz-Schmitt, P. Schnider, WO2015124541,
2015; c) H. Lu, R. B. Silverman, J. Med. Chem. 2006, 49, 7404.
CO2Et
2a
F3C
3aa
96%, 97% ee
1a
CF3
CO2Et
O
NH
3aa
2a
PPh2
P4
8
9
(S)-
Ph
P
H
O
Ph
CO2Et
PR3
Ph
Ph
F3C
H
R1
O
N
I
IV
OEt
10 a) Y. Wei, M. Shi, Acc. Chem. Res. 2010, 43, 1005; b) S.-X.
Wang, X. Han, F. Zhong, Y. Wang, Y. Lu, Synlett 2011, 2766; c)
Q.-Y. Zhao, Z. Lian, Y. Wei, M. Shi, Chem. Commun. 2012, 48,
1724; d) L.-W. Xu, ChemCatChem 2013, 5, 2775; e) Y. Wei, M.
Shi, Chem. Rev. 2013, 113, 6659; f) Y. Wei, M. Shi, Chem, Asian
J. 2014, 9, 2720; g) W. Li, J. Zhang, Chem. Soc. Rev. 2016, 45,
1657; h) T. Wang, X. Han, F. Zhong, W. Yao, Y. Lu, Acc. Chem.
Res. 2016, 49, 1369; i) H. Ni, W.-L. Chan, Y. Lu, Chem. Rev.
2018, 118, 9344; j) H. Guo, Y. C. Fan, Z. Sun, Y. Wu, O. Kwon,
Chem. Rev. 2018, 118, 10049.
11 Phosphine catalyst (S)-P4 was prepared according to Zhang’s
reports: a) a) X. Su, W. Zhou, Y. Li, J. Zhang, Angew. Chem. Int.
Ed. 2015, 54, 6874; b) W. Zhou, X. Su, M. Tao, C. Zhu, Q. Zhao,
J. Zhang, Angew. Chem. Int. Ed. 2015, 54, 14853; c) W. Zhou,
P. Chen, M. Tao, X. Su, Q. Zhao, J. Zhang, Chem. Commun.
2016, 52, 7612; d) H. Qiu, X. Chen, J. Zhang, Chem. Sci. 2019,
10, 10510.
12 CCDC 1503839 (3pa) contain the supplementary crystallogra-
phyic data for this paper.
13 G. Zhao, A. J. Souers, M. Voorbach, H. D. Falls, C. A. Collins, H.
Sham, R. M. Reilly, M. E. Brune, P. R. Kym, J. Med. Chem. 2008,
51, 380.
14 Y. Xia, Y. Liang, Y. Chen, M. Wang, L. Jiao, F. Huang, S. Liu, Y.
Li, Z.-X. Yu, J. Am. Chem. Soc. 2007, 129, 3470.
regionselective
addition
O
proton shift
Ph
CF3
1a
O
CO2Et
PR3
O
CO2Et
PR3
Ph
F3C
Ph
F3C
III
II
Scheme 5. Proposed mechanism.
In conclusion, we have developed a highly enantio- and
diastereoselective phosphine catalyzed [3+2] cycloadditions of
terminal allenoates with -perfluoroalkyl -enones. Diverse
trifluoromethylated cyclopentenes were delivered in good
yields with high regio-, diastereo-, and enantioselectivities. The
synthetic utilities of this methodology were further
demonstrated by the concise synthesis of trifluoromethylated
DGAT-1 inhibitor and other valuable building blocks. Efforts
toward the chiral phosphine catalyzed other asymmetric
transformations is currently underway in our group and will be
reported in due course.
We thank the financial support from the Fundamental
Research Funds for the Central Universities (21620354).
Notes and references
1
2
3
a) K. Muller, C. Faeh, F. Diederich, Science 2007, 317, 1881; b)
N. A. Meanwell, J. Med. Chem. 2011, 54, 2529; c) S. Purser, P.
R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 2008,
37, 320.
a) W. K. Hagmann, J. Med. Chem. 2008, 51, 4359; b) D. Barnes-
Seeman, M. Jain, L. Bell, S. Ferreira, S. Cohen, X.-H. Chen, J.
Amin, B. Snodgrass, P. Hatsis, ACS Med. Chem. Lett. 2013, 4,
514.
a) X. Yang, T. Wu, R. J. Phipps, F. D. Toste, Chem. Rev. 2015,
115, 826; b) J.-A. Ma, D. Cahard, Chem. Rev. 2004, 104, 6119.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins